These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 19923873

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Developing therapeutics for the diseases of protein misfolding.
    May BC, Govaerts C, Cohen FE.
    Neurology; 2006 Jan 24; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
    [Abstract] [Full Text] [Related]

  • 26. Amyloid fibrils.
    Johansson J.
    FEBS J; 2005 Dec 24; 272(23):5941. PubMed ID: 16302958
    [No Abstract] [Full Text] [Related]

  • 27. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [Abstract] [Full Text] [Related]

  • 28. Neurodegeneration and peroxidases.
    Everse J, Coates PW.
    Neurobiol Aging; 2009 Jul 28; 30(7):1011-25. PubMed ID: 18053617
    [Abstract] [Full Text] [Related]

  • 29. The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies?
    Windisch M, Wolf H, Hutter-Paier B, Wronski R.
    Neurodegener Dis; 2008 Jul 28; 5(3-4):218-21. PubMed ID: 18322395
    [Abstract] [Full Text] [Related]

  • 30. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG.
    Neurobiol Aging; 2006 Apr 28; 27(4):570-5. PubMed ID: 16481071
    [Abstract] [Full Text] [Related]

  • 31. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ, Fox SA, Caldwell GA, Caldwell KA.
    Neurosci Lett; 2008 Jul 11; 439(2):129-33. PubMed ID: 18514411
    [Abstract] [Full Text] [Related]

  • 32. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG.
    Drug News Perspect; 2007 Oct 11; 20(8):501-9. PubMed ID: 18080037
    [Abstract] [Full Text] [Related]

  • 33. Axonal transport defects: a common theme in neurodegenerative diseases.
    Roy S, Zhang B, Lee VM, Trojanowski JQ.
    Acta Neuropathol; 2005 Jan 11; 109(1):5-13. PubMed ID: 15645263
    [Abstract] [Full Text] [Related]

  • 34. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T, Lipton SA.
    Cell Death Differ; 2007 Jul 11; 14(7):1305-14. PubMed ID: 17431424
    [Abstract] [Full Text] [Related]

  • 35. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM, Amiji MM.
    Expert Opin Drug Deliv; 2009 Mar 11; 6(3):211-25. PubMed ID: 19290842
    [Abstract] [Full Text] [Related]

  • 36. Constitutive autophagy: vital role in clearance of unfavorable proteins in neurons.
    Komatsu M, Ueno T, Waguri S, Uchiyama Y, Kominami E, Tanaka K.
    Cell Death Differ; 2007 May 11; 14(5):887-94. PubMed ID: 17332773
    [Abstract] [Full Text] [Related]

  • 37. Functional diversity of protein fibrillar aggregates from physiology to RNA granules to neurodegenerative diseases.
    Furukawa Y, Nukina N.
    Biochim Biophys Acta; 2013 Aug 11; 1832(8):1271-8. PubMed ID: 23597596
    [Abstract] [Full Text] [Related]

  • 38. Principles of protein misfolding.
    Ramirez-Alvarado M.
    Prog Mol Biol Transl Sci; 2008 Aug 11; 84():115-60. PubMed ID: 19121701
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.
    Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G.
    Nat Rev Drug Discov; 2017 Jul 11; 16(7):487-511. PubMed ID: 28529316
    [Abstract] [Full Text] [Related]

  • 40. Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.
    Uversky VN, Kabanov AV, Lyubchenko YL.
    J Proteome Res; 2006 Oct 11; 5(10):2505-22. PubMed ID: 17022621
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.